Related Experiment Video

Updated: Apr 23, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

20.1K

Strategies for modern biomarker and drug development in oncology

Alan D Smith1, Desam Roda2, Timothy A Yap3

  • 1Drug Development Unit, Royal Marsden NHS Foundation Trust, Division of Clinical Studies, The Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK. alan.smith@icr.ac.uk.

Journal of Hematology & Oncology
|October 4, 2014
PubMed

Insights

Molecular cancer characterization identifies drivers for new therapies, but biomarker discovery for predicting treatment response needs acceleration. This review covers strategies and lessons learned for faster anticancer drug and biomarker development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Technological advances enable detailed molecular characterization of cancers.
  • Identification of key molecular drivers has led to novel anticancer therapeutics.
  • Clinical benefit is observed in selected patient populations, but predictive biomarker identification lags.

Purpose of the Study:

  • To discuss strategies for molecular characterization of cancers.
  • To highlight the importance of biomarkers in developing novel antitumor therapeutics.
  • To review successes and failures in oncology to accelerate drug and biomarker development.

Main Methods:

  • Review of current literature on cancer molecular characterization.
  • Analysis of strategies for biomarker discovery.
  • Examination of historical oncology successes and failures.

Main Results:

  • Increasing identification of molecular drivers fuels targeted therapies.
  • Predictive biomarker development remains a critical bottleneck.
  • Lessons from past oncology trials can inform future drug development.

Conclusions:

  • Effective molecular characterization is crucial for precision oncology.
  • Accelerating biomarker discovery is essential for maximizing therapeutic benefit.
  • Learning from past experiences is key to advancing anticancer drug development.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K